Aurora a regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2314-2323

  Song, Su Jung ^a   Song, Min Sup ^a   Kim, Soon Jung ^a   Kim, So Yeon ^a   Kwon, Seung Hae ^b   Kim, Jhin Gook ^c   Calvisi, Diego F ^d   Kang, Dongmin ^b   Lim, Dae Sik ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE PROMOTING COMPLEX; AURORA A KINASE; AURORA B KINASE; CELL CYCLE PROTEIN 20; CYCLINE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SERINE; AURORA KINASE; CDC20 PROTEIN, HUMAN; CELL CYCLE PROTEIN; PROTEIN SERINE THREONINE KINASE; RASSF1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INHIBITION KINETICS; MITOSIS; MUTANT; PRIORITY JOURNAL; PROMETAPHASE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA INTERFERENCE; TUMOR; UPREGULATION; BIOSYNTHESIS; CELL CYCLE G2 PHASE; CELL DIVISION; CELL FRACTIONATION; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HELA CELL; LUNG TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

CELL CYCLE PROTEINS; CELL DIVISION; G2 PHASE; HELA CELLS; HUMANS; LUNG NEOPLASMS; MITOSIS; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROMETAPHASE; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 65549154498     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3984     Document Type: Article

References (50)

1. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Riol 2001;2:21-32.
2. Marumoto T, Hirota T, Morisaki T, et al. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells 2002;7:1173-82.
3. Marumoto T, Zhang D, Saya H. Aurora-A-a guardian of poles. Nat Rev Cancer 2005;5:42-50.
4. Giet R( McLean D, Descamps S, et al. Drosophiia Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J Cell Biol 2002;156:437-51.
5. Giet R, Uzbekov R, Cubizolles V, et al. The Xenopus laevis aurora-related protein kinase pEg2 associates with and phosphorylates the kinesin-related protein XlEg5.J Riol Chem 1999;274:15005-13.
6. Hirota T, Kunitoku N, Sasayama T, et al. Aurora-A and an interacting activator, the L1M protein Ajuba, are required for mitotic commitment in human cells. Cell 2003;114:585-98.
7. Kunitoku N, Sasayama T, Marumoto T, et al. CENP-A phosphorylation by Aurora-A in prophase is required for enrichment of Aurora-R at inner centromeres and for kinetochore function. Dev Cell 2003;5;:853-64,
8. Liu Q, Ruderman JV. Aurora A, mitotic entry, and spindle bipolarity. Proc Natl Acad Sci USA 2006;103: 5811-6.
9. Eyers PA, Erikson E, Chen LG, et al. A novel mechanism for activation of the protein kinase Aurora A. Curr Biol 2003;13:691-97.
10. Bisehoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO j 1998;17;:3052-65.
11. Sen S, Zhou H, Zhang RD, et al. Amplification/ overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002;94:1320-9.
12. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/RTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20: 189-93.
13. Giet R, Petretti C, Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Riol 2005;15:241-50.
14. Kawajiri A, Yasui Y, Goto H, et al. Functional significance of the specific sites phosphorylated in desmin at cleavage furrow: Aurora-B may phosphorylate and regulate type III intermediate filaments during cytokinesis coordinatedly with Rho-kinase. Mol Biol Cell 2003;14:1489-500.
15. Murata-Hori M, Fumoto R, Fukuta Y, et al. Myosin II regulatory light chain as a novel substrate for A1M-1, an aurora/I pi lp-related kinase from rat. j Biochem (Tokyo) 2000;128:903-907.
16. Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005;65:3497-508.
17. Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21,3. Nat Genet 2000;25:315-9.
18. Tommasi S, Dammann R, Zhang Z, et al. Tumor susceptibility of Rassfla knockout mice. Cancer Res 2005;65:92-8.
19. van der Weyden L, Tachibana KK, Gonzalez MA, et al. The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Riol 2005;25:8356-67.
20. Song MS, Song SJ, Ayad NG, et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 2004;6:129-37.
21. Wang X, Di K, Zhang X, et al. Id-1 promotes chromosomal instability through modification of ARC/ C activity during mitosis in response to microtubule disruption. Oncogene 2008;27:4456-66.
22. Liu L, Tommasi S, Lee DH, et al. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 2003;22:8125-36.
23. Rong R, jin W, Zhang J, et al. Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene 2004;23:8216-30.
24. Baksh S, Tommasi S, Fenton S, et al. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Rax conformational change and cell death. Mol Cell 2005;18:637-50.
25. Oh Hj, Lee KK, Song SJ, et al. Role of the tumor suppressor RASSF1A in Mstl-mediated apoptosis. Cancer Res 2006;66:2562-9.
26. Song M, Song S, Kim S, et al. The tumour suppressor RASSFIA promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMRO J 2008;27:1863-74.
27. Liu L, Baier K, Dammann R, et al. The tumor suppressor RASSF1A does not interact with Cdc20, an activator of the anaphase-pronioting complex. Cell Cycle 2007;6:1663-5.
28. Rong R, Jiang LY( Sheikh MS, et al. Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSFlA-mediated microtubule interaction and M-phase cell cycle regulation. Oncogene 2007; 26:7700-8.
29. Song M, Song S, Kim S, et al. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the Gl-S transition. Oncogene 2008;27:3176-85.
30. Kufer TA, Sillje HH, Korner R, et al. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002;158:617-23.
31. Hauf S, Cole RW, LaTerra S, et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetoehore-mierotubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 2003; 161:281-94.
32. Calvisi D, Ladu S, Gorden A, et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 2007;117:2713-22.
33. Clute P, Pines J. Temporal and spatial control of cyclin Bl destruction in metaphase. Nat Cell Biol 1999;1: 82-7.
34. Lenart P, Petronezki M, Steegmaier M, et al. The small-molecule inhibitor Bl 2536 reveals novel insights into mitotic roles of polo-like kinase 1, Curr Biol 2007;17: 304-15.
35. Pines j. Mitosis: a matter of getting rid of the right protein at the right time. Trends Cell Biol 2006;16:55-63.
36. Mathe E. RASSF1A, the new guardian of mitosis. Nat Genet 2004;36:117-8.
37. Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 2007;27:3-16.
38. Hwang Es Ryu K, Paakkonen K, et al. Structural insight into dimeric interaction of the SARAH domains from Mstl and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci VJ S A 2007;104:9236-41.
39. Hannak E, Kirkharn M, Hyman AA, et al. Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans, j Cell Biol 2001;155:1109-16.
40. Jackson PK. Linking tumor suppression, DNA damage and the anaphase-promoting complex Trends Cell Biol 2004;14:331-4.
41. Hansen DV, Loktev AV, Ran KH, et al. Plkl regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFβTrCP-dependent destruction of the APC Inhibitor Emil. Mol Biol Cell 2004;15:5623-34.
42. Moshe Y, Boulaire J, Pagano M, et al. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyelosome. Proc Natl Acad Sci U S A 2004;101:7937-42.
43. Kraft C, Herzog F, Gieffers C, et al. Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J 2003;22:6598-609.
44. van Vugt MA, Medema RH. Polo-like kinase-1: activity measurement and RNAI-mediated knockdown. Methods Mol Biol 2005;296:355-69.
45. Geley S, Kramer E, Gieffers C, et al. Anaphase- promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint, J Cell Biol 2001;153:137-48.
46. Peters JM. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol Cell 2002;9:931-43.
47. Liu L, Guo C, Dammann R, et al. RASSF1A interacts with and activates the mitotic kinase Aurora-A. Oncogene 2008;27:6175-86.
48. Zhang D, Hirota T, Marumoto T, et al. Cre-loxP- controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 2004;23:8720-30.
49. Harrington EA, Behbington D, Moore J, et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004;10:262-7.
50. Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004;4:927-36.